Safety and Efficacy Study of TPI-287 in Neuroblastoma and Medulloblastoma
This study is ongoing, but not recruiting participants.
Van Andel Research Institute
Cortice Biosciences, Inc.
Information provided by (Responsible Party):
Giselle Sholler, Spectrum Health Hospitals
First received: November 28, 2011
Last updated: March 10, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is ongoing, but not recruiting participants.|
|Estimated Study Completion Date:||November 2018|
|Estimated Primary Completion Date:||November 2015 (Final data collection date for primary outcome measure)|